Cargando…

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma

GOALS: In this clinical study, we aimed to evaluate the role of circulating microRNA-200 family as a non-invasive tool to identify patients with cirrhosis-associated hepatocellular carcinoma (HCC). BACKGROUND: Prognosis of HCC remains poor with increasing incidence worldwide, mainly related to liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhayat, Sameer A., Hüsing, Anna, Senninger, Norbert, Schmidt, Hartmut H., Haier, Jörg, Wolters, Heiner, Kabar, Iyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598187/ https://www.ncbi.nlm.nih.gov/pubmed/26447841 http://dx.doi.org/10.1371/journal.pone.0140066

Ejemplares similares

MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2015)

Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2018)

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients
por: Dhayat, Sameer A., et al.
Publicado: (2021)

Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
por: Reese, Moritz, et al.
Publicado: (2020)

Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation
por: Bürger, Christin, et al.
Publicado: (2019)

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine
por: Hüsing, Anna, et al.
Publicado: (2015)

Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?
por: Kara, David, et al.
Publicado: (2018)

Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure
por: Dogan, Nurettin, et al.
Publicado: (2018)

Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant Recipients
por: Kabar, Iyad, et al.
Publicado: (2018)

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
por: Dhayat, Sameer A., et al.
Publicado: (2020)

Chronic liver disease promotes lesions of the colorectal adenoma-carcinoma sequence, independent of liver cirrhosis
por: Troschel, Amelie S., et al.
Publicado: (2019)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report
por: Seifert, Leon Louis, et al.
Publicado: (2016)

Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020
por: Wiegele, Patricia Nicole, et al.
Publicado: (2021)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines
por: Dhayat, Sameer A., et al.
Publicado: (2017)

Single-operator cholangioscopy for biliary complications in liver transplant recipients
por: Hüsing-Kabar, Anna, et al.
Publicado: (2017)

Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study
por: Gerth, Hans U., et al.
Publicado: (2017)

The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2014)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis
por: Florian, Anca, et al.
Publicado: (2020)

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure—A Retrospective Analysis*
por: Gerth, Hans U., et al.
Publicado: (2017)

Genome silencer therapy leading to ‘regression’ of cardiac amyloid load on cardiovascular magnetic resonance: a case report
por: Florian, Anca, et al.
Publicado: (2021)

MicroRNA200a Enhances Antitumor Effects in Combination with Doxorubicin in Hepatocellular Carcinoma
por: Cui, Xiao, et al.
Publicado: (2020)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

SERPINB5 and AKAP12 -- Expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf A, et al.
Publicado: (2010)

Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016)

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: MacKenzie, Scott M., et al.
Publicado: (2021)

Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians
por: Youssef, Samar Samir, et al.
Publicado: (2022)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
por: Kan, Casina WS, et al.
Publicado: (2012)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis
por: Lin, Haixia, et al.
Publicado: (2022)

MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma
por: Chen, Shu-ying, et al.
Publicado: (2017)

MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas
por: Urbschat, Steffi, et al.
Publicado: (2022)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_knckme0ou1u3f95ccioq4tarua